Indicators

Latest News about NTRA

Recent news which mentions NTRA

< Previous 1 2 3 4 5 6 7 Next >

Stocks That Hit 52-Week Lows On Wednesday

March 09, 2022

Mid-Morning Market Update: Markets Open Higher; Dow Jumps Over 600 Points

March 09, 2022

Analyst Ratings For Natera

March 08, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022

March 08, 2022

Natera: Q4 Earnings Insights

February 24, 2022

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company

February 24, 2022

Natera's Debt Overview

February 22, 2022

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow

February 20, 2022

Stocks That Hit 52-Week Lows On Friday

January 07, 2022

This fund company was an early believer in Tesla — it’s now making these bets

November 18, 2021

7 Stocks to Buy in November in Light of Their October Dip

November 15, 2021

Medicare Coverage For Natera's Signatera For Pan-Cancer Immunotherapy Monitoring

November 11, 2021

Why Cathie Wood Is Buying Beaten-Down CareDx

November 06, 2021

Natera Raises FY21 Sales Outlook After Mixed Q3 earnings

November 05, 2021

Natera Inc (NTRA) Q3 2021 Earnings Call Transcript

November 05, 2021

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO

November 04, 2021

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

October 31, 2021

CEO And President Of Natera Trades $2.4M In Company Stock

October 06, 2021

Notable Natera Insider Trades $3M In Company Stock

September 30, 2021

CEO And President Of Natera Trades $3.41 Million In Company Stock

September 27, 2021

Return on Capital Employed Overview: Natera

August 30, 2021

Natera Q2 Sales Tops Street Estimates On Higher Volumes, Raises FY21 Sales Outlook

August 06, 2021

Illumina Stock Will Be Unstoppable Once the Grail Acquisition Gets Approved

August 06, 2021

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

August 05, 2021

Analyzing Natera's Unusual Options Activity

August 04, 2021

What Does Natera's Debt Look Like?

August 03, 2021

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs

August 01, 2021

3 Stocks Insiders Are Buying

July 27, 2021

The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay

July 21, 2021

Expert Ratings For Natera

July 20, 2021

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.